Karl-Erik Andersson to Afferent Pathways
This is a "connection" page, showing publications Karl-Erik Andersson has written about Afferent Pathways.
Connection Strength
1.483
-
Hood B, Andersson KE. Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder. Int J Urol. 2013 Jan; 20(1):21-7.
Score: 0.376
-
Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn. 2010; 29(1):97-106.
Score: 0.310
-
Zhang X, Igawa Y, Ishizuka O, Nishizawa O, Andersson KE. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats. Naunyn Schmiedebergs Arch Pharmacol. 2003 May; 367(5):473-9.
Score: 0.195
-
Andersson KE. Bladder activation: afferent mechanisms. Urology. 2002 May; 59(5 Suppl 1):43-50.
Score: 0.182
-
Ito H, Aizawa N, Sugiyama R, Watanabe S, Takahashi N, Tajimi M, Fukuhara H, Homma Y, Kubota Y, Andersson KE, Igawa Y. Functional role of the transient receptor potential melastatin 8 (TRPM8) ion channel in the urinary bladder assessed by conscious cystometry and ex vivo measurements of single-unit mechanosensitive bladder afferent activities in the rat. BJU Int. 2016 Mar; 117(3):484-94.
Score: 0.114
-
Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, De Wachter S. Researching bladder afferents-determining the effects of ß(3) -adrenergic receptor agonists and botulinum toxin type-A. Neurourol Urodyn. 2011 Jun; 30(5):684-91.
Score: 0.085
-
Kanai A, Andersson KE. Bladder afferent signaling: recent findings. J Urol. 2010 Apr; 183(4):1288-95.
Score: 0.078
-
Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009 Nov; 56(5):810-9.
Score: 0.075
-
Gacci M, Andersson KE, Chapple C, Maggi M, Mirone V, Oelke M, Porst H, Roehrborn C, Stief C, Giuliano F. Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Eur Urol. 2016 07; 70(1):124-133.
Score: 0.029
-
Aizawa N, Iijima K, Rosenbaum JS, Downs TR, Igawa Y, Andersson KE, Wyndaele JJ. Comparison of the effects of oestrogen deficiency and old age on primary bladder afferent activity and voiding behaviour in the ageing female rat. BJU Int. 2011 Jul; 108(2 Pt 2):E10-6.
Score: 0.020
-
Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, Andersson KE, Högestätt ED, Zygmunt PM. Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol. 2008 Feb; 53(2):391-9.
Score: 0.017